IFNB1 and chronic hepatitis C virus infection: In the treatment of chronic hepatitis C, IFN-β and ribavirin therapy has been shown to produce therapeutic effects similar to those achieved by IFN-α or pegylated (Peg)-IFN-α and ribavirin therapy [10,11].